Formation Minerals, Inc. Announces Corporate Update
JACKSBORO, Texas, June 13, 2024 -- Formation Minerals, Inc. (OTCQB: FOMI) (“Formation” or the “Company”), a growing oil and gas company with a focus on the acquisition and management of oil and gas minerals and royalties, today provided an update on the Company’s...
Rodedawg (OTC: RWGI) Launches TikTok Shop to Expand into Global E-Commerce Market
Company E-commerce Effort Expands into 10 Billion Dollar Marketplace COSTA MESA, CA, June 12th, 2024 – Rodedawg International Industries, Inc. (OTC: RWGI), a prominent cannabis manufacturer and distributor, is excited to announce the launch of its own TikTok Shop....
SIPP Industries Announces Strategic R&D Agreement with Calypso Pharmaceuticals to Develop Nano-Emulsified Topical Targeting Melanoma
Costa Mesa, CA, June 11, 2024 - SIPP Industries, Inc. (OTC: SIPC), a multifaceted corporation specializing in the manufacturing and distribution of commercial and consumer products in the cannabis industry, is pleased to announce a Research and Development agreement...
SS Innovations’ SSi Mantra Surgical Robotic System Approved for Use in Indonesia
Fort Lauderdale, FL., June 11, 2024 - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global...
GK Financing LLC, a Subsidiary of American Shared Hospital Services, Announces Extension of Agreement with PeaceHealth Sacred Heart Medical Center at RiverBend
Extended 10-year Agreement to Upgrade Gamma Knife® Perfexion™ with Elekta Esprit San Francisco, CA, June 7, 2024 – GK Financing LLC (GKF), a subsidiary of American Shared Hospital Services (NYSE American: AMS), a leading provider of turnkey technology solutions for...
Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte’s VitaGraft Study
New York, June 3, 2024—Oncocyte’s (Nasdaq: OCX) VitaGraft Kidney™ diagnostic test for transplant monitoring has shown promising results in a Phase 2 clinical trial, published in the prestigious New England Journal of Medicine. The trial evaluated the test's...
Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus
Clinical testing of LP-310 expected to commence in mid-2024 Patient recruitment is underway for Phase 2a multicenter, dose-ranging study PITTSBURGH, PA., May 31, 2024 -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us” or the “Company”), a...
SS Innovations Engages BDO as its new Auditor
SS Innovations believes that the selection of BDO will facilitate uplisting of its common stock to a National Securities Exchange and reflects the Company’s commitment to transparent financial and accounting practices and regulatory compliance FORT LAUDERDALE, Fla.,...
AmpliTech Announces Receipt of Notice from Nasdaq Regaining Compliance
Hauppauge, NY, May 30, 2024 - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, and other communications networks, including the design of complete 5G/6G systems,...
BioStem Technologies to Sponsor MRO Better Half Dash
POMPANO BEACH, Fla., May 29, 2024 - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics, will sponsor the MRO Better Half Dash which will be held...